Eli Lilly’s $100 Million Investment in Dicerna Pharmaceuticals, Inc.

Ambrogio Visconti

Sidley represented Dicerna Pharmaceuticals Inc. (Nasdaq:DRNA) as co-counsel in connection with Dicerna’s sale and issuance of 5,414,185 shares of its common stock to Eli Lilly and…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now